Rapid development and use of patient-specific ctDNA biomarkers to avoid a “rash decision” in an ovarian cancer patient

Epithelial ovarian cancer (OvCa) is the most lethal female reproductive tract malignancy. A major clinical hurdle in patient management and treatment is that when using current surveillance technologies 80% of patients will be clinically diagnosed as having had a complete clinical response to primar...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandya, Deep, Camacho, Sandra Catalina, Padron, Maria M., Camacho-Vanegas, Olga, Billaud, Jean-Noel, Beddoe, Ann-Marie, Irish, Jon, Yoxtheimer, Lorene, Kalir, Tamara, RoseFigura, Jordan, Dottino, Peter, Martignetti, John A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory Press 2019
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913138/
https://www.ncbi.nlm.nih.gov/pubmed/31628202
http://dx.doi.org/10.1101/mcs.a004648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913138/
https://www.ncbi.nlm.nih.gov/pubmed/31628202
http://dx.doi.org/10.1101/mcs.a004648

Ejemplares similares